Safety and Tolerability of a Novel Anti-HER2 Antibody–Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation Study

por Meric-Bernstam, Funda, Calvo, Emiliano, Lee, Keun Seok, Moreno, Victor, Park, Yeon Hee, Rha, Sun Young, Chalasani, Pavani, Zhong, Wei, Zhou, Li, Pirie-Shepherd, Steven, Leung, Abraham C.F., Curigliano, Giuseppe
Publicado 2023